Intermediate histotripsy dose boosts tumor regression in liver cancer model
Since its development at the University of Michigan more than two decades ago, histotripsy has progressed from an experimental method for mechanically destroying tissue to a US Food and Drug Administration (FDA)–cleared treatment ...
Aug 13, 2026
0
3









